BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17192488)

  • 21. Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue.
    Hontecillas R; Diguardo M; Duran E; Orpi M; Bassaganya-Riera J
    Clin Nutr; 2008 Oct; 27(5):764-72. PubMed ID: 18778878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity.
    Matsuzawa-Nagata N; Takamura T; Ando H; Nakamura S; Kurita S; Misu H; Ota T; Yokoyama M; Honda M; Miyamoto K; Kaneko S
    Metabolism; 2008 Aug; 57(8):1071-7. PubMed ID: 18640384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
    Moore GB; Pickavance LC; Briscoe CP; Clapham JC; Buckingham RE; Wilding JP
    Diabetes Obes Metab; 2008 Mar; 10(3):251-63. PubMed ID: 18269641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.
    Goldfine AB
    Curr Opin Cardiol; 2008 Sep; 23(5):502-11. PubMed ID: 18670263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
    Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
    Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice.
    Calpe-Berdiel L; EscolĂ -Gil JC; Rotllan N; Blanco-Vaca F
    Metabolism; 2008 Nov; 57(11):1497-501. PubMed ID: 18940385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
    Hubbard B; Doege H; Punreddy S; Wu H; Huang X; Kaushik VK; Mozell RL; Byrnes JJ; Stricker-Krongrad A; Chou CJ; Tartaglia LA; Lodish HF; Stahl A; Gimeno RE
    Gastroenterology; 2006 Apr; 130(4):1259-69. PubMed ID: 16618417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S; Adachi S; Manabe E; Mizushima K; Hattori T; Okuda T; Nakabe N; Handa O; Takagi T; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 May; 23(3):259-65. PubMed ID: 17523018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
    Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
    Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
    Takahashi S; Zenimaru Y; Suzuki J; Miyamori I
    Nihon Ronen Igakkai Zasshi; 2009; 46(6):545-50. PubMed ID: 20139652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
    J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
    Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?
    Suzuki T; Tsunoda-Kubota M; Aoyama J; Futami-Suda S; Hashimoto M; Igari Y; Watanabe K; Kigawa Y; Nakano H; Oba K
    J Nippon Med Sch; 2013; 80(3):211-7. PubMed ID: 23832405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acid sequestrants: glucose-lowering mechanisms.
    Prawitt J; Staels B
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
    Zhang Y; Guo K; LeBlanc RE; Loh D; Schwartz GJ; Yu YH
    Diabetes; 2007 Jun; 56(6):1647-54. PubMed ID: 17360978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
    Suzuki T; Oba K; Futami-Suda S; Suzuki K; Ouchi M; Igari Y; Matsumura N; Watanabe K; Kigawa Y; Nakano H
    J Nippon Med Sch; 2007 Feb; 74(1):81-4. PubMed ID: 17384485
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.